Strategic Regulatory Partner for Success in United Kingdom

Greetings from

Pharma Wizard United Kingdom

Growing consumer demand and moderate accessibility to emerging healthcare technologies make the United Kingdom (UK) a lucrative market for pharmaceutical, medical device, and biotech manufacturers. The Medicines and Healthcare products Regulatory Agency (MHRA) governs the region’s Regulatory processes. With varying procedures—Centralised Procedure (CP), National Procedure (NP), Decentralised Procedure (DCP), and Mutual Recognition Procedure (MRP)—the UK’s Regulatory pathway can be complex and demanding for market authorizations. Pharma Wizard, with a dedicated operational center in the UK, supports foreign manufacturers with localized Regulatory Affairs and operational guidance for all required Regulatory procedures.

Industries We Serve in United Kingdom

Medicinal Product Regulatory Support in United Kingdom

The United Kingdom (UK) upholds one of the world’s most robust healthcare policies, attracting major pharmaceutical companies globally. Medicinal products can only be marketed in the UK after proper registration and receiving approval from the Medicines and Healthcare Products Regulatory Agency (MHRA). As per Directive 2001/83/EC, any new medicinal product must be registered through a Marketing Authorization Application (MAA), following specific procedures.

Medical Devices Regulatory Support in United Kingdom

Following Brexit, the UK continues to revise and enhance its regulatory framework for medical devices. Regulations differ based on geography — Great Britain (GB) and Northern Ireland (NI). The Medicines and Healthcare Products Regulatory Agency (MHRA) serves as the regulatory body overseeing medical device compliance in the UK. Northern Ireland adheres to the European Union Medical Devices Regulation (EU MDR) 2017/745 and In Vitro Diagnostic Devices Regulation (IVDR) 2017/746. For non-UK manufacturers, appointing a UK Responsible Person (UK RP) is mandatory to ensure compliance and facilitate a smooth UK Medical Device Registration process.

Cosmetics Regulatory Support in United Kingdom

The United Kingdom (UK) has officially left the European Union (EU), and the transition period for Brexit ended on December 31, 2020. Hence, from January 01, 2021, manufacturers and importers must abide by the New Cosmetics Regulation in the UK and the existing EU Cosmetics Regulation in all remaining EU countries.

Food Supplements Regulatory Support in United Kingdom

The Food Standards Agency (FSA) is responsible for food safety and hygiene across the United Kingdom (UK). Due to Brexit, the UK became the third country on December 31, 2020, and published a batch of technical guidance documents for businesses on the implications of its exit from the European Union (EU). Now, in the post-Brexit era, a Food Business Operator (FBO) UK, who is the responsible operator, must be identified, and the address should be mentioned on the label of food products.

Chemicals Regulatory Support in United Kingdom

Cleaning and disinfectant products are called/identified and regulated differently across countries and regions, making it very challenging for the industry to place these products in different markets. After Brexit, the UK has framed a separate individual set of chemical/product legislation, which is an amended version of the EU’s existing legislation. In the UK, disinfectant products are classified as biocides in a similar way as in Europe. After Brexit, the UK framed its own disinfectant regulation like Europe, which is referred to as GB BPR. Biocides under the GB BPR are categorized in the same way as in Europe as Group I Disinfectants having below PT types.

Pharma Wizard Offerings

Strategic Regulatory Consulting
Regulatory roadmap for market access
Regulatory Affairs & Regulatory Intelligence
Registration pathways and license management services
Market Authorizations (MAA)
End-to-end operational support
Regulatory submission guidance and preparation
510(k) Submissions
GLP, GCP
Pharmacovigilance
Safety Reports
CE marking
Patient Information Leaflet (PIL) and Summary of Product Characteristics services
Regulatory Labeling
In-country representation

Pharma Wizard Advantages

Strategic and well-versed local regulatory knowledgebase – with UK MHRA
Expert Regulatory team with proven global RA expertise
Proactive and Collaborative approach
Quick turnarounds and faster time-to-market
Keeping abreast with region-specific legislation and Regulatory guidelines

FBR

Company Profile

Portfolio

Presentation

Order

Food & Food Supplements Product Services

Categories Supported

Sustainability Services